Kate Cappell, PhD
Kate is a seasoned leader and researcher who, along with her team, sets the tone and builds the backbone of every study conducted by the Real World Evidence team. By adding structure and consistency around everything we do, she plays an integral part in the credibility and success of our studies.
AREA OF EXPERTISE
Real World Data / Evidence Research analytics Study ImplementationKate Cappell, PhD is Director of Research Analytics, Real World Evidence at Veradigm, where she oversees an expert team of research analysts and medical writers, conducting real-world, retrospective database and prospective studies using EHR, registry, and healthcare claims data. Her team plays a critical role in the foundation of every study by developing study protocols, building detailed medical code sets, communicating study requirements to programmers, data interpretation, data communication in the form of reports, abstracts/posters, and manuscripts, and day-to-day project management.
Prior to joining the Veradigm team, Dr. Cappell spent 10 years as an analyst conducting real-world evidence studies for Life Sciences clients using healthcare claims data and 1.5 years as the Product Manager for the MarketScan Research Databases at IBM Watson Health. Dr. Cappell holds a PhD in Cognitive Psychology from the University of Michigan.
References to published articles by this expert
- Hunter Gibble T, Chinthammit C, Ward JM, Cappell K, Sedgley R, Bonafede M, Liao B, Hankosky ER. Real-World Use of Tirzepatide among Individuals without Evidence of Type 2 Diabetes: Results from the Veradigm® Database. Diabetes Obes Metab 2025; 27: 3185–3194.
- Landi SN, Garofalo DC, Reimbaeva M, Scott AM, Jiang L, Cappell K, Lewandowski D, Bonafede M, Brzozowski K, Drebert Z, Temple M, Tawadrous M, Pixton GC, Alami N, Kelly SP, Aliabadi N, Begier E, Swan JT. Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults. JAMA Netw Open. 2024 Nov 4;7(11):e2446010. doi: 10.1001/jamanetworkopen.2024.46010. PMID: 39560940; PMCID: PMC11577139.
- McGovern I, Cappell K, Bogdanov AN, Haag MDM. The Number of Influenza Risk Factors Informs an Adult’s Increased Potential of Severe Influenza Outcomes: A Multi-Season Cohort Study from 2015 to 2020. Open Forum Infectious Diseases 2024; ofae203.
- McGovern I, Cappell K, Bogdanov AN, Haag MDM. Incidence of Influenza-Related Medical Encounters and the Associated Healthcare Resource Use and Complications across Adult Age Groups in the United States during the 2015-2020 Influenza Seasons. Clin Infect Dis 2024; 79: 778–786.
- Shah S, Cappell K, Sedgley R, Pelletier C, Jacob R, Bonafede M, Yadlapati R. Diagnosis and Treatment Patterns among Patients with Newly Diagnosed Helicobacter Pylori Infection in the United States 2016–2019. Sci Rep 2023; 13: 1375.
- Yadlapati R, Cappell K, Sedgley R, Pelletier C, Jacob R, Bonafede M, Shah SC. A Linked Electronic Medical Record-Claims Analysis of the Clinical and Economic Outcomes of Patients Coded for Erosive Esophagitis in the United States. Adv Ther 2023; 40: 5489–5501.
- McGovern I, Bogdanov A, Cappell K, Whipple S, Haag M. Influenza Vaccine Uptake in the United States before and during the COVID-19 Pandemic. Vaccines 2022; 10: 1610.
- Bonafede MM, Korytowsky B, Singh P, Cai Q, Cappell K, Jariwala-Parikh K, Sill B, Parikh ND. Treatment Patterns and Economic Burden by Lines of Therapy among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy. J Gastrointest Cancer 2020; 51: 217–226.